There was weak evidence of a small association between leptin and aggressive prostate cancer (Fig. 2b, overall OR 1.03, 95% CI 1.00 to 1.06 per 2.5 ng/ml increase in leptin, p = 0.02). This evidence concerns the gene LEP and prostate cancer.